Reducing Costs and Improving Outcomes for Medicaid Managed Care Enrollees Diagnosed with Postpartum Preeclampsia

OBJECTIVE

Postpartum preeclampsia is the highest contributor to overall maternity costs in the United States and the leading cause of maternal morbidity and mortality. Early symptom identification and diagnosis can prevent severe complications and reduce the need for costly medical services, such as emergency room visits and lengthy hospital stays. However, research indicates that many women do not attend postpartum visits, which can delay postpartum preeclampsia diagnoses. Alternative screening tools, such as telehealth, home visits, and remote patient monitoring, can help women at risk for postpartum preeclampsia identify symptoms and seek necessary care sooner. We will assess the use of various screening tools to identify and diagnose postpartum preeclampsia in Medicaid managed care enrollees. These findings will inform efforts to support early identification of symptoms and diagnosis through screening to help reduce Medicaid costs and improve health outcomes for enrollees.

TIMELINE

• July 15, 2025
  Announced
• Today
  Office of Evaluation and Inspections In-Progress
• Est FY2027
  Estimated Fiscal Year for Project Completion

---